Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 1161-1166 |
Journal / Publication | Hypertension |
Volume | 17 |
Issue number | 6 SUPPL. 2 |
Publication status | Published - Jun 1991 |
Externally published | Yes |
Link(s)
Abstract
Six control dogs, six dogs treated with 1.5 mg/kg b.i.d. quinapril, and six dogs treated with 8 mg/kg q.d. minoxidil underwent 6 hours daily of hindquarter compression for 9 weeks. Minoxidil significantly decreased baseline blood pressure (-17 mm Hg; p≤0.01), whereas quinapril decreased baseline blood pressure 11 mm Hg but not significantly (p=0.15). Hindquarter compression elicited blood pressure increases in all three groups (control +18, quinapril +13, minoxidil +19 mm Hg). After 9 weeks, left ventricular mass in control dogs increased 22% (p
Research Area(s)
- Angiotensin converting enzyme inhibitors, Dog studies, Echocardiography, Hypertrophy, Minoxidil
Citation Format(s)
Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension. / Julius, Stevo; Li, Ying; Brant, David et al.
In: Hypertension, Vol. 17, No. 6 SUPPL. 2, 06.1991, p. 1161-1166.
In: Hypertension, Vol. 17, No. 6 SUPPL. 2, 06.1991, p. 1161-1166.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review